FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Nidan Laboratories and Healthcare IPO and Omnipotent Industries IPO.
Nidan Laboratories and Healthcare IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Omnipotent Industries IPO is a SME Fixed Price Issue proposed to list at BSE SME.
Nidan Laboratories and Healthcare IPO | Omnipotent Industries IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | First Overseas Capital Limited | Inventure Merchant Banker Services Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Nidan Laboratories and Healthcare IPO is up to ₹50.00 Cr whereas the issue size of the Omnipotent Industries IPO is up to ₹18.90 Cr. The final issue price of Nidan Laboratories and Healthcare IPO is ₹125.00 per share and of Omnipotent Industries IPO is ₹63.00 per share.
Nidan Laboratories and Healthcare IPO | Omnipotent Industries IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹125.00 per share | ₹63.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1000 shares | 2000 shares |
Fresh Issue Size | 30,00,000 shares | |
Fresh Issue Size (Amount) | ||
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 40,00,000 shares | |
Issue Size Total (Amount) | up to ₹50.00 Cr | up to ₹18.90 Cr |
Nidan Laboratories and Healthcare IPO opens on Oct 28, 2021, while Omnipotent Industries IPO opens on Nov 16, 2021. The closing date of Nidan Laboratories and Healthcare IPO and Omnipotent Industries IPO is Nov 02, 2021, and Nov 22, 2021, respectively.
Nidan Laboratories and Healthcare IPO | Omnipotent Industries IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Oct 28, 2021 | Nov 16, 2021 |
Issue Close | Nov 02, 2021 | Nov 22, 2021 |
Basis Of Allotment (Tentative) | Nov 09, 2021 | Nov 25, 2021 |
Initiation of Refunds (Tentative) | Nov 10, 2021 | Nov 26, 2021 |
Credit of Share (Tentative) | Nov 11, 2021 | Nov 29, 2021 |
Listing date (Tentative) | Nov 12, 2021 | Nov 29, 2021 |
Anchor Lockin End date 1 | Dec 09, 2021 | Dec 25, 2021 |
Anchor Lockin End date 2 | Feb 07, 2022 | Feb 23, 2022 |
Nidan Laboratories and Healthcare IPO P/E ratio is , as compared to Omnipotent Industries IPO P/E ratio of .
Nidan Laboratories and Healthcare IPO | Omnipotent Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99% | 56.23% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 71.22% | 28.35% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Nidan Laboratories and Healthcare IPO retail investors (RII) are offered 19,00,000 shares while in Omnipotent Industries IPO retail investors are offered 19,00,000 shares. Qualified institutional buyers (QIB) are offered in Nidan Laboratories and Healthcare IPO and in Omnipotent Industries IPO.
Nidan Laboratories and Healthcare IPO | Omnipotent Industries IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 2,00,000 shares | 1,52,000 shares |
QIB | ||
NII | 19,00,000 shares | 14,24,000 shares |
RII | 19,00,000 shares | 14,24,000 shares |
Employee | ||
Others | ||
Total | 38,00,000 shares | 28,48,000 shares |
Nidan Laboratories and Healthcare IPO subscribed 1.80x in total, whereas Omnipotent Industries IPO subscribed 1.17x.
Nidan Laboratories and Healthcare IPO | Omnipotent Industries IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 0.15x | 1.00x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.44x | 1.34x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.80x | 1.17x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|